Iressa 250 mg

  • cancer chemotherapy


Iressa 250 mg (Gefitinib) tablet from AstraZeneca is a cancer chemotherapy prescription medication used for certain breast, lung and other cancers.It interferes with the growth of cancer cells and slows their growth and spread in the body. Iressa is mainly used in the treatment of non-small cell lung. Iressa may also be used for purposes other than those listed in this medication guide. It has a pack size of 30 tabs (3 strips of 10 tabs each).

Manufacturer: AstraZeneca

Additional Information

Dosage Information:

Iressa should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.

Take each dose of this medicine with a full glass of water.

Iressa can be taken with or without food.

Your doctor will determine the correct amount and frequency of treatment with Iressa depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.

It is important to take Iressa regularly to get the most benefit.

Your doctor may want you to have blood tests and other medical evaluations during treatment with Iressa to monitor progress and side effects.

Your healthcare provider will store this medicine as directed by the manufacturer. If you are storing Iressa at home, follow the directions provided by your healthcare provider.

Side Effects

Contact your doctor immediately if you experience any of the following serious side effects from Iressa:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
  • lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
  • severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
  • eye pain or irritation.

Other, less serious Iressa side effects may be more likely to occur. Continue taking Iressa and talk to your doctor if you experience:

  • mild to moderate nausea, vomiting, loss of appetite, or diarrhea;
  • skin rash, dryness, itching, or acne; or
  • weakness

Pack Size